NS · Chemicals

Kobo Biotech Ltd (531541)

Chemicals & Petrochemicals

Kobo Biotech Ltd (531541) is listed on NS in the Chemicals sector. Industry: Chemicals & Petrochemicals. As of 2026-07-10, reported market cap is $172.50M, P/E ratio is -3.43, net margin is -53,561.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 531541

Market cap
$172.50M
P/E ratio
-3.43
Net margin
-53,561.4%

Kobo Biotech Ltd (531541) — FAQ

What is Kobo Biotech Ltd's market cap?

Kobo Biotech Ltd (531541) has a reported market cap of $172.50M (data as of 2026-07-10).

What is 531541's P/E ratio?

The price-to-earnings (P/E) ratio for Kobo Biotech Ltd (531541) is -3.43 (data as of 2026-07-10).

Does Kobo Biotech Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Kobo Biotech Ltd (531541). Check the MyAverix Finance app for the latest dividend data.

What sector is Kobo Biotech Ltd in?

Kobo Biotech Ltd (531541) is classified in the Chemicals sector (Chemicals & Petrochemicals industry).

What exchange is 531541 listed on?

531541 is listed on NS.

What is Kobo Biotech Ltd's net margin?

Kobo Biotech Ltd (531541) reports a net margin of -53,561.4% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

App Store Google Play